Adverse reactions related to the SINOPHARM vaccine in health personnel of the Arequipa Regional Police Hospital Julio Pinto Manrique
DOI:
https://doi.org/10.53673/th.v2i1.131Abstract
Objective: It was to determine the adverse reactions related to the SINOPHARM vaccine in the health personnel of the Regional Police Hospital "Julio Pinto Manrique" of Arequipa.
Method: It was a non-experimental, basic, cross-sectional and prospective investigation, the population was made up of health personnel who work in the aforementioned hospital, the question form used by the Centers for control was loaded on a virtual platform. and disease prevention (CDC), answering a total of 162 people.
Results: The health personnel in both doses presented mostly side effects such as headache and pain, swelling, redness in the vaccine puncture area, and allergic reactions such as dizziness and tachycardia.
Conclusion: Side effects occurred in the 1st dose in 66.73% in the 2nd dose in 58.64%; allergic reactions in the 1st dose occurred in 8.02% and in the 2nd in 5.56% in the health personnel of the aforementioned Hospital.
References
Wu Z, McGoogan J. haracteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020.
Organización Mundial de la Salud. Cronología de la respuesta de la OMS a la COVID-19. 2021.
Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, et al. he origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(11).
Lu R, Zhao X, Li JNP, Yang B, Wu H, al e. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: p. 565-574.
Ministerio de Sanidad. Actualización nº 13. Neumonía por nuevo coronavirus (2019-nCoV) en Wuhan, provincia de Hubei, (China). Ministerio de Sanidad. 2020.
Organización Mundial de la Salud. Nuevo coronavirus -Tailandia (procedente de China). Ginebra. Organización Mundial de la Salud. 2020.
Organización Mundial de la Salud. Nuevo coronavirus - República de Corea (procedente de China). Ginebra. Organización Mundial de la Salud. 2020.
Organización Mundial de la Salud. Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. Ginebra. Organización Mundial de la Salud. 2020.
Briggs H. Coronavirus: cómo se estrecha el cerco sobre el pangolín como probable transmisor del patógeno que causa el covid-19. Londres: BBC. 2020.
Adhanom-Ghebreyesus T. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Ginebra, Suiza: World Health Organization. [Online]; 2020. Acceso 1 de juniode 2021. Disponible en: HYPERLINK "https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020" https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 .
World Health Organization. Draft landscape of COVID-19 candidate vaccines. [Online]; 2020. Acceso 1 de juniode 2021. Disponible en: HYPERLINK "https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines" https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines .
Organización Mundial de la Salud. Enfermedad por coronavirus (COVID-19): Investigación y desarrollo de vacunas. [Online]; 2020. Acceso 1 de juniode 2021. Disponible en: HYPERLINK "https://www.who.int/es/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccine-research-and-development" https://www.who.int/es/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccine-research-and-development .
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020; 382: p. 727-33.
Ministerio de Salud Argentina. Manual del Vacunador Vacuna SINOPHARM. [Online].; 2021. Acceso 1 de KIMOP de 2021. Disponible en: HYPERLINK "file:///D:/USUARIO/Downloads/manual-vacunador-sinopharm_12-3-2021.pdf" file:///D:/USUARIO/Downloads/manual-vacunador-sinopharm_12-3-2021.pdf .
Americas TB Coalition. revista: Lista completa de reacciones adversas de la vacuna SINOPHARM. [Online]; 2021. Acceso 1 de juniode 2021. Disponible en: HYPERLINK "https://actbistas.org/la-lista-completa-de-reacciones-adversas-de-la-vacuna-sinopharm-de-china/" https://actbistas.org/la-lista-completa-de-reacciones-adversas-de-la-vacuna-sinopharm-de-china/
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Susana Mercedes Guillén Pinto
This work is licensed under a Creative Commons Attribution 4.0 International License.
This license allows others to redistribute, remix, tweak, and build upon your work, even with commercial penalties, as long as you take credit for the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of the materials subject to the license.
